Neratinib Efficacy and Circulating Tumor DNA Detection of <i>HER2</i> Mutations in <i>HER2</i> Nonamplified Metastatic Breast CancerX. Cynthia, Matthew J. Ellis, Melinda L. Telli et al.|Clinical Cancer Research|2017Cited by 191
Phase II trial of neratinib for HER2 mutated, non-amplified metastatic breast cancer (HER2<sup>mut</sup> MBC).X. Cynthia, Matthew J. Ellis, Ron Bose et al.|Journal of Clinical Oncology|2016Cited by 17